Richard E. Buller - 08 Apr 2024 Form 4 Insider Report for Celcuity Inc. (CELC)

Role
Director
Signature
/s/ Eric O. Madson as Attorney-in-Fact for Richard E. Buller pursuant to Power of Attorney previously filed.
Issuer symbol
CELC
Transactions as of
08 Apr 2024
Transactions value $
$0
Form type
4
Filing time
10 Apr 2024, 16:38:27 UTC
Previous filing
23 Feb 2024
Next filing
26 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CELC Common Stock 8,081 08 Apr 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELC Stock Option (right to buy) Gift $0 -4,555 -100% $0* 0 08 Apr 2024 Common Stock 4,555 $5.5 Direct F2
transaction CELC Stock Option (right to buy) Gift $0 +4,555 $0 4,555 08 Apr 2024 Common Stock 4,555 $5.5 By Trust F2, F3
transaction CELC Stock Option (right to buy) Gift $0 -12,654 -100% $0* 0 08 Apr 2024 Common Stock 12,654 $5.1 Direct F2
transaction CELC Stock Option (right to buy) Gift $0 +12,654 $0 12,654 08 Apr 2024 Common Stock 12,654 $5.1 By Trust F2, F3
transaction CELC Stock Option (right to buy) Gift $0 -2,310 -100% $0* 0 08 Apr 2024 Common Stock 2,310 $5.5 Direct F2
transaction CELC Stock Option (right to buy) Gift $0 +2,310 $0 2,310 08 Apr 2024 Common Stock 2,310 $5.5 By Trust F2, F3
transaction CELC Stock Option (right to buy) Gift $0 -19,558 -100% $0* 0 08 Apr 2024 Common Stock 19,558 $5.5 Direct F2
transaction CELC Stock Option (right to buy) Gift $0 +19,558 $0 19,558 08 Apr 2024 Common Stock 19,558 $5.5 By Trust F2, F3
holding CELC Stock Option (right to buy) 8,733 08 Apr 2024 Common Stock 8,733 $9.58 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 1,958 shares of restricted stock for which risks of forfeiture lapse on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.
F2 100% vested.
F3 On April 8, 2024, the Reporting Person transferred this stock option to a living trust, of which the Reporting Person and his spouse are the trustees and beneficiaries. The Reporting Person continues to beneficially own these securities held by the trust.
F4 This Option will vest and become exercisable on April 30, 2024, or if earlier, the date of the Company's 2024 Annual Meeting of Stockholders.